Patient reported outcomes in anti-PD-1/PD-L1 inhibitor immunotherapy registration trials: FDA analysis of data submitted and future directions - King-Kallimanis, B L; Howie, L J; Roydhouse, J K (Clin Trials, 2019)
, et al.